Subscribe To
Sana biotechnology to present at the guggenheim healthcare talks 5th annual oncology conference
SEATTLE, Feb. 02, 2023 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as ...
February 2, 2023, 9:05 pm
There's a crop of great biotech companies ready to be acquired, says mpm's christiana bardon
Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins 'The Exchange' to discuss tailwinds in the pharmaceutical and ...
February 2, 2023, 3:15 pm
The 7 most undervalued biotech stocks to buy in february 2023
You don't have to be particularly astute to recognize the importance of the most undervalued biotech st...
February 2, 2023, 2:19 pm
Biondvax presenting at bio ceo & investor conference
JERUSALEM, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd . ( Nasdaq: BVXV ), a biotechnology company focused on ...
February 2, 2023, 2:15 pm
Xilio therapeutics to present at the guggenheim healthcare talks oncology day
WALTHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-o...
February 2, 2023, 12:30 pm
Vera therapeutics announces pricing of public offering of class a common stock
BRISBANE, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc., (NasdaqGM: VERA; “Vera”), a late-stage biotechnology company focused...
February 2, 2023, 2:52 am
Senti bio to present at the svb securities global biopharma conference
SOUTH SAN FRANCISCO, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company inno...
February 1, 2023, 9:05 pm
Eye dna synthesis advances in active biotech etf arkg
It's hard to imagine it now, but at the turn of the millennium, the big advancement in technology was not the latest phone app, it was the Human Genom...
February 1, 2023, 2:38 pm
Century therapeutics to present at upcoming investor conferences
PHILADELPHIA, Feb. 01, 2023 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripote...
February 1, 2023, 12:00 pm
Morphosys: negative enterprise value biotech, but lack of near-term catalyst
MorphoSys AG is a German commercial-stage biopharmaceutical company founded in 1992 with more than 100+ pipeline candidates. We believe MorphoSys's tw...
February 1, 2023, 9:21 am
Recursion to participate in upcoming investor conference
SALT LAKE CITY , Feb. 1, 2023 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by d...
February 1, 2023, 8:01 am
Enveric biosciences to present at the bio ceo & investor conference
CAMBRIDGE, Mass.--( BUSINESS WIRE )--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the...
February 1, 2023, 7:33 am
Mpc therapeutics closes chf 1.5m seed-funding round
MPC Therapeutics closes CHF 1.5M seed-funding round. MPC Therapeutics, a biotechnology spin-off of UNIGE focused on metabolism and cellular rejuvenati...
February 1, 2023, 6:44 am
Arcturus' mrna platform: the future of quick and efficient vaccine delivery
Arcturus is revolutionizing biotechnology with its cutting-edge mRNA vaccines and delivery systems. They recently teamed up with CSL Seqirus, a leadin...
February 1, 2023, 4:01 am
Alexandria real estate shows once more why it's not your typical office reit
Alexandria Real Estate Equities delivered excellent fourth-quarter and full-year 2022 results. Focusing on the biotech/life sciences industry has help...
January 31, 2023, 6:55 pm
Labu: leveraged biotech etf review
biotech stocks have pulled back and offer better risk to reward for investors, Direxion Daily S&P ...
January 31, 2023, 6:20 pm
Biggest earnings week of the season: key stocks to watch
This week is undoubtedly the most important week of earnings season. Andrew Rocco highlights key industries to watch including big tech, biotech, and ...
January 31, 2023, 10:15 am
Novabay pharmaceuticals to present at the virtual sequire biotechnology conference on february 2, 2023
EMERYVILLE, Calif.--( BUSINESS WIRE )--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that Justin Hall, CEO, will present a company ov...
January 31, 2023, 6:50 am
Genmab: high-quality biotech darling, but lacks meaningful catalysts in the near term
Genmab (GMAB) is a Danish commercial biopharma company with a leading technology and track record in innovative antibody-based therapeutics. Darzalex ...
January 31, 2023, 6:48 am
Legend biotech: cartitude-4 study a success
Legend biotech and partner Johnson & Johnson announced positive topline results from the CARTITUDE-4 tr...
January 31, 2023, 2:17 am